← Open Payments lookup

DORIS ANSAH: Open Payments

NPI 1285391136 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$826 in 32 payments from 9 companies in 2025. Trend: 2023 $22 · 2024 $235 · 2025 $826

Food & beverage: $826
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.3$231
Vanda Pharmaceuticals Inc.7$225
ABBVIE INC.12$152
Teva Pharmaceuticals USA, Inc.3$62
Neurocrine BioSciences, Inc.2$54
Lundbeck LLC2$48
Alkermes, Inc.1$21
Collegium Pharmaceutical, Inc.1$17
TMS NeuroHealth Centers Inc.1$15

Products named: FANAPT, VRAYLAR, REXULTI, ABILIFY MAINTENA, INGREZZA, UZEDY, AUSTEDO XR, ARISTADA.

Industry payments across MD — which companies pay providers there.